Skip to main content
. 2020 Nov 18;58(12):e01098-20. doi: 10.1128/JCM.01098-20

TABLE 2.

Performance characteristics of the Carba-R NxG and commercially available Carba-R assays in a genotypically diverse cohort of P. aeruginosa (n = 123)

Test and targeta True positive (n) False positive (n) True negative (n) False negative (n) Test performance [% (CI)]
Sensitivity Specificity
Carba-R NxG
    VIM 31 0 92 0 100 (89–100) 100 (95–100)
    IMP 26 0 97 0 100 (87–100) 100 (96–100)
    NDM 13 0 110 0 100 (75–100) 100 (97–100)
    SPM 14 0 109 0 100 (77–100) 100 (97–100)
    KPC 8 0 115 0 100 (63–100) 100 (97–100)
    GES 14 0 110 0 100 (75–100) 100 (97–100)
    Non-CP 0 20 b
Commercially available Carba-R
    VIM 31 0 92 0 100% (89–100) 100% (95–100)
    IMP 15 0 97 11 58% (37–77) 100% (96–100)
    NDM 13 0 110 0 100% (75–100) 100% (97–100)
    SPM 0 0 109 14
    KPC 8 0 115 0 100% (63–100) 100% (97–100)
    GES 0 0 109 14
    Non-CP 0 20
a

Carba-R NxG, research-use-only Carba-R NxG; Carba-R, commercially available Carba-R; VIM, Verona integron-encoded metallo-β-lactamase; IMP, imipenemase; NDM, New Delhi metallo-β-lactamase; SPM, Sao Paulo metallo-β-lactamase; KPC, Klebsiella pneumoniae carbapenemase; GES, Guiana extended spectrum; Non-CP, non-carbapenemase producing.

b

—, not calculated.